Earlier this month, the ongoing BEEHIVE (Bridging the Epidemiology and Evolution of HIV in Europe) project reported their detection of the new variant of subtype-B HIV-1, the most common type of ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

HIV clinicians will need a basic understanding of the most important characteristics of low-level resistant variants as they pertain to their impact on therapy in order to best utilize these new ...

Throughout modern medical history, Americans have underestimated or dismissed emerging health threats until the consequences ...

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...

“The discovery of this novel HIV-1 lineage highlights the continuing need to monitor closely for the emergence of new HIV variants. This demonstrates that HIV evolution is an ongoing process. The ...

The new vaccines, directed against the KP family, are from Pfizer and Moderna. The vaccinations are interchangeable and ...

During untreated HIV infection, many different variations of the virus are made within a single person. But when a new ...

Researchers at Université de Montréal's affiliated hospital research center, the CRCHUM, say the discovery could help lessen ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...

HIV clinicians will need a basic understanding of the most important characteristics of low-level resistant variants as they pertain to their impact on therapy in order to best utilize these new ...